https://subium.com/profile/warren.senate.gov/post/3le7syrcecc25
Kamala not promising the teamsters to keep Lina Khan is one of the most insane unforced L's of a campaign that consisted entirely of unforced L's I swear to god
She ended that meeting by telling the teamsters that she would win "with or without" them. lol
If anything happens - how long until the Trump administration blocks the lowered price? And then - of course - the dems will say they tried and... Vote!
---
Edit
Can a judge step in and kill the lowered price?
I think if somebody drops something heavy and the noise removed the parliamentarian then they have to shred the bill
I assume Trump forgot all about the parliamentarian. If one day soon seemingly out of the blue he starts saying how the GOP needs to fire the parliamentarian on "day one" of his administration - we'll know he saw them mentioned on Fox News or somebody in real life reminded him that the parliamentarian exists or or he saw a parliamentarian joke on Hexbear.
I love to beg, plead, and grovel for what should already be a human right.
After working for the US government for a few years now, the second they start talking about "fighting" and not "results" is a huge fucking red flag.
They can fix the issue, they are just choosing not to and are finding their parliamentarian to kill it.
"fighting" and not "results"
Ah, that's it. I couldn't put my finger on why Bluesky libs annoy me 10x as much as r/politics libs. They love this shit...
Show
They get so mad at me when I ask the tiny question "How?" Also - it doesn't help that I have a visceral hatred of the BIG FONT IMAGE. I don't know why I hate it so much but I do.
They just keep coming out with new combos with slightly different strengths, drug combos, formulations, etc and touting it as the best new thing for COPD/asthma and docs prescribe it
these people who think vaccines are such bigtime money makers have never even heard of breo
Check out the prices on some of the newer ones, Bevespi for example
Show
Or Breztri holy shit
Show
Fools think vaccine series at $100-1000/each per person per lifetime is where the money get made....
When I see the Breztri has 120 doses/device I already know what the dose is going to be:
The usual Breztri Aerosphere dosage for adults with COPD is 2 puffs (sprays) twice per day.
4 doses/day x 30 days = 120/device ; $676 = 1 month supply
= $8112/year
In the marketing materials the largest number 52% is attribute to "one study of people with COPD,† most of whom did not have a history of flare-ups in the last year". So people who are not really very sick, if you can get them started on some med now they could be on it for 10 or 20 years! Others will get added along the way so this cost will be double, trippled, etc; and this for just ONE disease.
So basically the way these things work is they don't necessarily get a patent on any actual new drugs, you can use any old drugs. (Sometimes they make new drug though.) They make the little plasticdoohicky you squeeze to get the medication, and the mix of medications. (This is a very rudimentary understanding, please correct me if you know better details.)
Under communism, the plastic doohickies should be reusable and refillable.
No you've pretty much got the gist of it. They can get a new patent on a new formulation (aerosol vs powder vs aerosphere) on the same medications. The same thing they do with capsules, tablets, ER tablets, ER capsules, solutions, suspensions, granules, injections, patches, you can go on. Same med, same effect, minimal new R&D needed compared to developing and testing a whole new drug, and cash in on an exclusive patent for 10ish years.
It's crazy how each substantially similar innovation arrives about 9ish years after the last one. Must be the natural cycle of drug research?
Not that there would be any generic manufacturers chomping at the bit to make the doohickies anyway. Think of the insulin or epinephrine pens. Drugs are cheap. Doohicky is expensive. Probably all sorts of regulations, certifications etc related to manufacturing them not to mention distribution channels, insurance coverageand who knows what barriers.
